世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Point-of-Care Glucose Testingの世界市場の洞察、2028年までの予測


Global Point-of-Care Glucose Testing Market Insights, Forecast to 2028

入院中の糖尿病患者の血糖値管理には、正確な近距離血糖値測定システムが必要です。 市場分析とインサイト医療用ポイントオブケアグルコース検査の世界市場 COVID-19のパンデミックにより、ポイントオブケアグ... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年2月4日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

入院中の糖尿病患者の血糖値管理には、正確な近距離血糖値測定システムが必要です。
市場分析とインサイト医療用ポイントオブケアグルコース検査の世界市場
COVID-19のパンデミックにより、ポイントオブケアグルコース検査の世界市場規模は、2022年には6億490.5万米ドルと推定され、2028年には7億5,450万米ドルに再調整されると予測されています(CAGR 2.6%)。この健康危機による経済的変化を十分に考慮した上で、0.5uL/0.6uLは2021年のPoint-of-Care Glucose Testing世界市場の%を占めていますが、ポストCOVID-19期間のCAGRは改訂され、2028年には100万米ドルになると予測されています。一方、病院のセグメントは、この予測期間中、年率%で変化しています。
中国のPoint-of-Care Glucose Testingの市場規模は2021年に100万米ドル、米国と欧州のPoint-of-Care Glucose Testingの市場規模はそれぞれ100万米ドルと100万米ドルとなっています。2021年の市場規模は、米国が100万ドル、欧州が100万ドルとなっていますが、中国と欧州はそれぞれ100万ドル、100万ドルとなっています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。欧州のポイントオブケアグルコース検査市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%です。
Point-of-Care Glucose Testingの世界的な主要メーカーには、Roche Holding AG、Abbott、Nova Biomedical、Prodigy Diabetes Care、Johnson & Johnson、Nipro、ACON Laboratories, Inc.、Trividia Health, Inc.、Panasonic Healthcare Holdingsなどがあります。2021年には、世界の上位5社の売上高シェアは約%となっています。
Point-of-Care Glucose Testingのスコープとセグメント
Point-of-Care Glucose Testing市場は、タイプ別とアプリケーション別に分類されています。世界のPoint-of-Care Glucose Testing市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。
タイプ別セグメント
0.5uL/0.6uL
1uL
1.5uL
その他
用途別セグメント
病院
クリニック
家庭用
会社別
ロシュ・ホールディングAG
アボット
ノバ・バイオメディカル
プロディジー・ダイアビーティーズ・ケア
ジョンソン・エンド・ジョンソン
ニプロ
エーコン・ラボラトリーズ・インク
トリビディア・ヘルス社
パナソニック・ヘルスケア・ホールディングス
EKFダイアグノスティクス
オムロン
ビー・ブラウン
77 エレクトロニカ
AgaMatrix
テルモ
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジアパシフィック
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
中近東・アフリカ
トルコ
サウジアラビア
U.A.E.


ページTOPに戻る


目次

1 Study Coverage
1.1 Point-of-Care Glucose Testing Product Introduction
1.2 Market by Type
1.2.1 Global Point-of-Care Glucose Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.5uL/0.6uL
1.2.3 1uL
1.2.4 1.5uL
1.2.5 Others
1.3 Market by Application
1.3.1 Global Point-of-Care Glucose Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Point-of-Care Glucose Testing Sales Estimates and Forecasts 2017-2028
2.2 Global Point-of-Care Glucose Testing Revenue Estimates and Forecasts 2017-2028
2.3 Global Point-of-Care Glucose Testing Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Point-of-Care Glucose Testing Sales by Region
2.4.1 Global Point-of-Care Glucose Testing Sales by Region (2017-2022)
2.4.2 Global Sales Point-of-Care Glucose Testing by Region (2023-2028)
2.5 Global Point-of-Care Glucose Testing Revenue by Region
2.5.1 Global Point-of-Care Glucose Testing Revenue by Region (2017-2022)
2.5.2 Global Point-of-Care Glucose Testing Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Point-of-Care Glucose Testing Sales by Manufacturers
3.1.1 Global Top Point-of-Care Glucose Testing Manufacturers by Sales (2017-2022)
3.1.2 Global Point-of-Care Glucose Testing Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Point-of-Care Glucose Testing in 2021
3.2 Global Point-of-Care Glucose Testing Revenue by Manufacturers
3.2.1 Global Point-of-Care Glucose Testing Revenue by Manufacturers (2017-2022)
3.2.2 Global Point-of-Care Glucose Testing Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Point-of-Care Glucose Testing Revenue in 2021
3.3 Global Point-of-Care Glucose Testing Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Point-of-Care Glucose Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Point-of-Care Glucose Testing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Point-of-Care Glucose Testing Sales by Type
4.1.1 Global Point-of-Care Glucose Testing Historical Sales by Type (2017-2022)
4.1.2 Global Point-of-Care Glucose Testing Forecasted Sales by Type (2023-2028)
4.1.3 Global Point-of-Care Glucose Testing Sales Market Share by Type (2017-2028)
4.2 Global Point-of-Care Glucose Testing Revenue by Type
4.2.1 Global Point-of-Care Glucose Testing Historical Revenue by Type (2017-2022)
4.2.2 Global Point-of-Care Glucose Testing Forecasted Revenue by Type (2023-2028)
4.2.3 Global Point-of-Care Glucose Testing Revenue Market Share by Type (2017-2028)
4.3 Global Point-of-Care Glucose Testing Price by Type
4.3.1 Global Point-of-Care Glucose Testing Price by Type (2017-2022)
4.3.2 Global Point-of-Care Glucose Testing Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Point-of-Care Glucose Testing Sales by Application
5.1.1 Global Point-of-Care Glucose Testing Historical Sales by Application (2017-2022)
5.1.2 Global Point-of-Care Glucose Testing Forecasted Sales by Application (2023-2028)
5.1.3 Global Point-of-Care Glucose Testing Sales Market Share by Application (2017-2028)
5.2 Global Point-of-Care Glucose Testing Revenue by Application
5.2.1 Global Point-of-Care Glucose Testing Historical Revenue by Application (2017-2022)
5.2.2 Global Point-of-Care Glucose Testing Forecasted Revenue by Application (2023-2028)
5.2.3 Global Point-of-Care Glucose Testing Revenue Market Share by Application (2017-2028)
5.3 Global Point-of-Care Glucose Testing Price by Application
5.3.1 Global Point-of-Care Glucose Testing Price by Application (2017-2022)
5.3.2 Global Point-of-Care Glucose Testing Price Forecast by Application (2023-2028)
6 North America
6.1 North America Point-of-Care Glucose Testing Market Size by Type
6.1.1 North America Point-of-Care Glucose Testing Sales by Type (2017-2028)
6.1.2 North America Point-of-Care Glucose Testing Revenue by Type (2017-2028)
6.2 North America Point-of-Care Glucose Testing Market Size by Application
6.2.1 North America Point-of-Care Glucose Testing Sales by Application (2017-2028)
6.2.2 North America Point-of-Care Glucose Testing Revenue by Application (2017-2028)
6.3 North America Point-of-Care Glucose Testing Market Size by Country
6.3.1 North America Point-of-Care Glucose Testing Sales by Country (2017-2028)
6.3.2 North America Point-of-Care Glucose Testing Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Point-of-Care Glucose Testing Market Size by Type
7.1.1 Europe Point-of-Care Glucose Testing Sales by Type (2017-2028)
7.1.2 Europe Point-of-Care Glucose Testing Revenue by Type (2017-2028)
7.2 Europe Point-of-Care Glucose Testing Market Size by Application
7.2.1 Europe Point-of-Care Glucose Testing Sales by Application (2017-2028)
7.2.2 Europe Point-of-Care Glucose Testing Revenue by Application (2017-2028)
7.3 Europe Point-of-Care Glucose Testing Market Size by Country
7.3.1 Europe Point-of-Care Glucose Testing Sales by Country (2017-2028)
7.3.2 Europe Point-of-Care Glucose Testing Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Point-of-Care Glucose Testing Market Size by Type
8.1.1 Asia Pacific Point-of-Care Glucose Testing Sales by Type (2017-2028)
8.1.2 Asia Pacific Point-of-Care Glucose Testing Revenue by Type (2017-2028)
8.2 Asia Pacific Point-of-Care Glucose Testing Market Size by Application
8.2.1 Asia Pacific Point-of-Care Glucose Testing Sales by Application (2017-2028)
8.2.2 Asia Pacific Point-of-Care Glucose Testing Revenue by Application (2017-2028)
8.3 Asia Pacific Point-of-Care Glucose Testing Market Size by Region
8.3.1 Asia Pacific Point-of-Care Glucose Testing Sales by Region (2017-2028)
8.3.2 Asia Pacific Point-of-Care Glucose Testing Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Point-of-Care Glucose Testing Market Size by Type
9.1.1 Latin America Point-of-Care Glucose Testing Sales by Type (2017-2028)
9.1.2 Latin America Point-of-Care Glucose Testing Revenue by Type (2017-2028)
9.2 Latin America Point-of-Care Glucose Testing Market Size by Application
9.2.1 Latin America Point-of-Care Glucose Testing Sales by Application (2017-2028)
9.2.2 Latin America Point-of-Care Glucose Testing Revenue by Application (2017-2028)
9.3 Latin America Point-of-Care Glucose Testing Market Size by Country
9.3.1 Latin America Point-of-Care Glucose Testing Sales by Country (2017-2028)
9.3.2 Latin America Point-of-Care Glucose Testing Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Point-of-Care Glucose Testing Market Size by Type
10.1.1 Middle East and Africa Point-of-Care Glucose Testing Sales by Type (2017-2028)
10.1.2 Middle East and Africa Point-of-Care Glucose Testing Revenue by Type (2017-2028)
10.2 Middle East and Africa Point-of-Care Glucose Testing Market Size by Application
10.2.1 Middle East and Africa Point-of-Care Glucose Testing Sales by Application (2017-2028)
10.2.2 Middle East and Africa Point-of-Care Glucose Testing Revenue by Application (2017-2028)
10.3 Middle East and Africa Point-of-Care Glucose Testing Market Size by Country
10.3.1 Middle East and Africa Point-of-Care Glucose Testing Sales by Country (2017-2028)
10.3.2 Middle East and Africa Point-of-Care Glucose Testing Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche Holding AG
11.1.1 Roche Holding AG Corporation Information
11.1.2 Roche Holding AG Overview
11.1.3 Roche Holding AG Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Holding AG Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Holding AG Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Overview
11.2.3 Abbott Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 Nova Biomedical
11.3.1 Nova Biomedical Corporation Information
11.3.2 Nova Biomedical Overview
11.3.3 Nova Biomedical Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nova Biomedical Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nova Biomedical Recent Developments
11.4 Prodigy Diabetes Care
11.4.1 Prodigy Diabetes Care Corporation Information
11.4.2 Prodigy Diabetes Care Overview
11.4.3 Prodigy Diabetes Care Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Prodigy Diabetes Care Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Prodigy Diabetes Care Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Nipro
11.6.1 Nipro Corporation Information
11.6.2 Nipro Overview
11.6.3 Nipro Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Nipro Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nipro Recent Developments
11.7 ACON Laboratories, Inc.
11.7.1 ACON Laboratories, Inc. Corporation Information
11.7.2 ACON Laboratories, Inc. Overview
11.7.3 ACON Laboratories, Inc. Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ACON Laboratories, Inc. Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ACON Laboratories, Inc. Recent Developments
11.8 Trividia Health, Inc.
11.8.1 Trividia Health, Inc. Corporation Information
11.8.2 Trividia Health, Inc. Overview
11.8.3 Trividia Health, Inc. Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Trividia Health, Inc. Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Trividia Health, Inc. Recent Developments
11.9 Panasonic Healthcare Holdings
11.9.1 Panasonic Healthcare Holdings Corporation Information
11.9.2 Panasonic Healthcare Holdings Overview
11.9.3 Panasonic Healthcare Holdings Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Panasonic Healthcare Holdings Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Panasonic Healthcare Holdings Recent Developments
11.10 EKF Diagnostics
11.10.1 EKF Diagnostics Corporation Information
11.10.2 EKF Diagnostics Overview
11.10.3 EKF Diagnostics Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 EKF Diagnostics Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 EKF Diagnostics Recent Developments
11.11 Omron
11.11.1 Omron Corporation Information
11.11.2 Omron Overview
11.11.3 Omron Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Omron Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Omron Recent Developments
11.12 B. Braun
11.12.1 B. Braun Corporation Information
11.12.2 B. Braun Overview
11.12.3 B. Braun Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 B. Braun Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 B. Braun Recent Developments
11.13 77 Elektronika
11.13.1 77 Elektronika Corporation Information
11.13.2 77 Elektronika Overview
11.13.3 77 Elektronika Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 77 Elektronika Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 77 Elektronika Recent Developments
11.14 AgaMatrix
11.14.1 AgaMatrix Corporation Information
11.14.2 AgaMatrix Overview
11.14.3 AgaMatrix Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 AgaMatrix Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 AgaMatrix Recent Developments
11.15 Terumo
11.15.1 Terumo Corporation Information
11.15.2 Terumo Overview
11.15.3 Terumo Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Terumo Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Terumo Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Point-of-Care Glucose Testing Industry Chain Analysis
12.2 Point-of-Care Glucose Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Point-of-Care Glucose Testing Production Mode & Process
12.4 Point-of-Care Glucose Testing Sales and Marketing
12.4.1 Point-of-Care Glucose Testing Sales Channels
12.4.2 Point-of-Care Glucose Testing Distributors
12.5 Point-of-Care Glucose Testing Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Point-of-Care Glucose Testing Industry Trends
13.2 Point-of-Care Glucose Testing Market Drivers
13.3 Point-of-Care Glucose Testing Market Challenges
13.4 Point-of-Care Glucose Testing Market Restraints
14 Key Findings in The Global Point-of-Care Glucose Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Glycemic control in hospitalized patients with diabetes requires accurate near-patient glucose monitoring systems.
Market Analysis and Insights: Global Point-of-Care Glucose Testing Market
Due to the COVID-19 pandemic, the global Point-of-Care Glucose Testing market size is estimated to be worth US$ 6490.5 million in 2022 and is forecast to a readjusted size of US$ 7584.5 million by 2028 with a CAGR of 2.6% during the review period. Fully considering the economic change by this health crisis, 0.5uL/0.6uL accounting for % of the Point-of-Care Glucose Testing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Point-of-Care Glucose Testing market size is valued at US$ million in 2021, while the US and Europe Point-of-Care Glucose Testing are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Point-of-Care Glucose Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Point-of-Care Glucose Testing include Roche Holding AG, Abbott, Nova Biomedical, Prodigy Diabetes Care, Johnson & Johnson, Nipro, ACON Laboratories, Inc., Trividia Health, Inc. and Panasonic Healthcare Holdings, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Point-of-Care Glucose Testing Scope and Segment
Point-of-Care Glucose Testing market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Point-of-Care Glucose Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
0.5uL/0.6uL
1uL
1.5uL
Others
Segment by Application
Hospital
Clinic
Household
By Company
Roche Holding AG
Abbott
Nova Biomedical
Prodigy Diabetes Care
Johnson & Johnson
Nipro
ACON Laboratories, Inc.
Trividia Health, Inc.
Panasonic Healthcare Holdings
EKF Diagnostics
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Point-of-Care Glucose Testing Product Introduction
1.2 Market by Type
1.2.1 Global Point-of-Care Glucose Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 0.5uL/0.6uL
1.2.3 1uL
1.2.4 1.5uL
1.2.5 Others
1.3 Market by Application
1.3.1 Global Point-of-Care Glucose Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Point-of-Care Glucose Testing Sales Estimates and Forecasts 2017-2028
2.2 Global Point-of-Care Glucose Testing Revenue Estimates and Forecasts 2017-2028
2.3 Global Point-of-Care Glucose Testing Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Point-of-Care Glucose Testing Sales by Region
2.4.1 Global Point-of-Care Glucose Testing Sales by Region (2017-2022)
2.4.2 Global Sales Point-of-Care Glucose Testing by Region (2023-2028)
2.5 Global Point-of-Care Glucose Testing Revenue by Region
2.5.1 Global Point-of-Care Glucose Testing Revenue by Region (2017-2022)
2.5.2 Global Point-of-Care Glucose Testing Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Point-of-Care Glucose Testing Sales by Manufacturers
3.1.1 Global Top Point-of-Care Glucose Testing Manufacturers by Sales (2017-2022)
3.1.2 Global Point-of-Care Glucose Testing Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Point-of-Care Glucose Testing in 2021
3.2 Global Point-of-Care Glucose Testing Revenue by Manufacturers
3.2.1 Global Point-of-Care Glucose Testing Revenue by Manufacturers (2017-2022)
3.2.2 Global Point-of-Care Glucose Testing Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Point-of-Care Glucose Testing Revenue in 2021
3.3 Global Point-of-Care Glucose Testing Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Point-of-Care Glucose Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Point-of-Care Glucose Testing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Point-of-Care Glucose Testing Sales by Type
4.1.1 Global Point-of-Care Glucose Testing Historical Sales by Type (2017-2022)
4.1.2 Global Point-of-Care Glucose Testing Forecasted Sales by Type (2023-2028)
4.1.3 Global Point-of-Care Glucose Testing Sales Market Share by Type (2017-2028)
4.2 Global Point-of-Care Glucose Testing Revenue by Type
4.2.1 Global Point-of-Care Glucose Testing Historical Revenue by Type (2017-2022)
4.2.2 Global Point-of-Care Glucose Testing Forecasted Revenue by Type (2023-2028)
4.2.3 Global Point-of-Care Glucose Testing Revenue Market Share by Type (2017-2028)
4.3 Global Point-of-Care Glucose Testing Price by Type
4.3.1 Global Point-of-Care Glucose Testing Price by Type (2017-2022)
4.3.2 Global Point-of-Care Glucose Testing Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Point-of-Care Glucose Testing Sales by Application
5.1.1 Global Point-of-Care Glucose Testing Historical Sales by Application (2017-2022)
5.1.2 Global Point-of-Care Glucose Testing Forecasted Sales by Application (2023-2028)
5.1.3 Global Point-of-Care Glucose Testing Sales Market Share by Application (2017-2028)
5.2 Global Point-of-Care Glucose Testing Revenue by Application
5.2.1 Global Point-of-Care Glucose Testing Historical Revenue by Application (2017-2022)
5.2.2 Global Point-of-Care Glucose Testing Forecasted Revenue by Application (2023-2028)
5.2.3 Global Point-of-Care Glucose Testing Revenue Market Share by Application (2017-2028)
5.3 Global Point-of-Care Glucose Testing Price by Application
5.3.1 Global Point-of-Care Glucose Testing Price by Application (2017-2022)
5.3.2 Global Point-of-Care Glucose Testing Price Forecast by Application (2023-2028)
6 North America
6.1 North America Point-of-Care Glucose Testing Market Size by Type
6.1.1 North America Point-of-Care Glucose Testing Sales by Type (2017-2028)
6.1.2 North America Point-of-Care Glucose Testing Revenue by Type (2017-2028)
6.2 North America Point-of-Care Glucose Testing Market Size by Application
6.2.1 North America Point-of-Care Glucose Testing Sales by Application (2017-2028)
6.2.2 North America Point-of-Care Glucose Testing Revenue by Application (2017-2028)
6.3 North America Point-of-Care Glucose Testing Market Size by Country
6.3.1 North America Point-of-Care Glucose Testing Sales by Country (2017-2028)
6.3.2 North America Point-of-Care Glucose Testing Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Point-of-Care Glucose Testing Market Size by Type
7.1.1 Europe Point-of-Care Glucose Testing Sales by Type (2017-2028)
7.1.2 Europe Point-of-Care Glucose Testing Revenue by Type (2017-2028)
7.2 Europe Point-of-Care Glucose Testing Market Size by Application
7.2.1 Europe Point-of-Care Glucose Testing Sales by Application (2017-2028)
7.2.2 Europe Point-of-Care Glucose Testing Revenue by Application (2017-2028)
7.3 Europe Point-of-Care Glucose Testing Market Size by Country
7.3.1 Europe Point-of-Care Glucose Testing Sales by Country (2017-2028)
7.3.2 Europe Point-of-Care Glucose Testing Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Point-of-Care Glucose Testing Market Size by Type
8.1.1 Asia Pacific Point-of-Care Glucose Testing Sales by Type (2017-2028)
8.1.2 Asia Pacific Point-of-Care Glucose Testing Revenue by Type (2017-2028)
8.2 Asia Pacific Point-of-Care Glucose Testing Market Size by Application
8.2.1 Asia Pacific Point-of-Care Glucose Testing Sales by Application (2017-2028)
8.2.2 Asia Pacific Point-of-Care Glucose Testing Revenue by Application (2017-2028)
8.3 Asia Pacific Point-of-Care Glucose Testing Market Size by Region
8.3.1 Asia Pacific Point-of-Care Glucose Testing Sales by Region (2017-2028)
8.3.2 Asia Pacific Point-of-Care Glucose Testing Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Point-of-Care Glucose Testing Market Size by Type
9.1.1 Latin America Point-of-Care Glucose Testing Sales by Type (2017-2028)
9.1.2 Latin America Point-of-Care Glucose Testing Revenue by Type (2017-2028)
9.2 Latin America Point-of-Care Glucose Testing Market Size by Application
9.2.1 Latin America Point-of-Care Glucose Testing Sales by Application (2017-2028)
9.2.2 Latin America Point-of-Care Glucose Testing Revenue by Application (2017-2028)
9.3 Latin America Point-of-Care Glucose Testing Market Size by Country
9.3.1 Latin America Point-of-Care Glucose Testing Sales by Country (2017-2028)
9.3.2 Latin America Point-of-Care Glucose Testing Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Point-of-Care Glucose Testing Market Size by Type
10.1.1 Middle East and Africa Point-of-Care Glucose Testing Sales by Type (2017-2028)
10.1.2 Middle East and Africa Point-of-Care Glucose Testing Revenue by Type (2017-2028)
10.2 Middle East and Africa Point-of-Care Glucose Testing Market Size by Application
10.2.1 Middle East and Africa Point-of-Care Glucose Testing Sales by Application (2017-2028)
10.2.2 Middle East and Africa Point-of-Care Glucose Testing Revenue by Application (2017-2028)
10.3 Middle East and Africa Point-of-Care Glucose Testing Market Size by Country
10.3.1 Middle East and Africa Point-of-Care Glucose Testing Sales by Country (2017-2028)
10.3.2 Middle East and Africa Point-of-Care Glucose Testing Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche Holding AG
11.1.1 Roche Holding AG Corporation Information
11.1.2 Roche Holding AG Overview
11.1.3 Roche Holding AG Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Holding AG Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Holding AG Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Overview
11.2.3 Abbott Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Recent Developments
11.3 Nova Biomedical
11.3.1 Nova Biomedical Corporation Information
11.3.2 Nova Biomedical Overview
11.3.3 Nova Biomedical Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Nova Biomedical Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Nova Biomedical Recent Developments
11.4 Prodigy Diabetes Care
11.4.1 Prodigy Diabetes Care Corporation Information
11.4.2 Prodigy Diabetes Care Overview
11.4.3 Prodigy Diabetes Care Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Prodigy Diabetes Care Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Prodigy Diabetes Care Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Nipro
11.6.1 Nipro Corporation Information
11.6.2 Nipro Overview
11.6.3 Nipro Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Nipro Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nipro Recent Developments
11.7 ACON Laboratories, Inc.
11.7.1 ACON Laboratories, Inc. Corporation Information
11.7.2 ACON Laboratories, Inc. Overview
11.7.3 ACON Laboratories, Inc. Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ACON Laboratories, Inc. Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ACON Laboratories, Inc. Recent Developments
11.8 Trividia Health, Inc.
11.8.1 Trividia Health, Inc. Corporation Information
11.8.2 Trividia Health, Inc. Overview
11.8.3 Trividia Health, Inc. Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Trividia Health, Inc. Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Trividia Health, Inc. Recent Developments
11.9 Panasonic Healthcare Holdings
11.9.1 Panasonic Healthcare Holdings Corporation Information
11.9.2 Panasonic Healthcare Holdings Overview
11.9.3 Panasonic Healthcare Holdings Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Panasonic Healthcare Holdings Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Panasonic Healthcare Holdings Recent Developments
11.10 EKF Diagnostics
11.10.1 EKF Diagnostics Corporation Information
11.10.2 EKF Diagnostics Overview
11.10.3 EKF Diagnostics Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 EKF Diagnostics Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 EKF Diagnostics Recent Developments
11.11 Omron
11.11.1 Omron Corporation Information
11.11.2 Omron Overview
11.11.3 Omron Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Omron Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Omron Recent Developments
11.12 B. Braun
11.12.1 B. Braun Corporation Information
11.12.2 B. Braun Overview
11.12.3 B. Braun Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 B. Braun Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 B. Braun Recent Developments
11.13 77 Elektronika
11.13.1 77 Elektronika Corporation Information
11.13.2 77 Elektronika Overview
11.13.3 77 Elektronika Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 77 Elektronika Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 77 Elektronika Recent Developments
11.14 AgaMatrix
11.14.1 AgaMatrix Corporation Information
11.14.2 AgaMatrix Overview
11.14.3 AgaMatrix Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 AgaMatrix Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 AgaMatrix Recent Developments
11.15 Terumo
11.15.1 Terumo Corporation Information
11.15.2 Terumo Overview
11.15.3 Terumo Point-of-Care Glucose Testing Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Terumo Point-of-Care Glucose Testing Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Terumo Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Point-of-Care Glucose Testing Industry Chain Analysis
12.2 Point-of-Care Glucose Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Point-of-Care Glucose Testing Production Mode & Process
12.4 Point-of-Care Glucose Testing Sales and Marketing
12.4.1 Point-of-Care Glucose Testing Sales Channels
12.4.2 Point-of-Care Glucose Testing Distributors
12.5 Point-of-Care Glucose Testing Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Point-of-Care Glucose Testing Industry Trends
13.2 Point-of-Care Glucose Testing Market Drivers
13.3 Point-of-Care Glucose Testing Market Challenges
13.4 Point-of-Care Glucose Testing Market Restraints
14 Key Findings in The Global Point-of-Care Glucose Testing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る